Why the study?
Does neoadjuvant radiochemotherapy improve the rate of recurrence in patients with giant retroperitoneal dedifferentiated liposarcoma?
Does neoadjuvant radiochemotherapy improve the rate of recurrence in patients with giant retroperitoneal dedifferentiated liposarcoma?
Neoadjuvant radiochemotherapy may improve recurrence rates in patients undergoing resection for giant retroperitoneal dedifferentiated liposarcoma.
May reduce recurrence after resection; hypothesis-generating and requires randomized confirmation before practice change.
Even in case of giant retroperitoneal liposarcoma, complete resection is possible and remains the principal treatment. The rate of recurrence was improved in patients with neoadjuvant radiochemotherapy.
No takes yet. Share an insight, caveat, or question.
Bachmann et al. (2020) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: